Literature DB >> 10447832

Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in chickens.

H García Ovando1, N Gorla, C Luders, G Poloni, C Errecalde, G Prieto, I Puelles.   

Abstract

The pharmacokinetics of enrofloxacin (EFX) and ciprofloxacin (CFX) was investigated in broiler chickens. Each antimicrobial was administered intravenously at a dose of 5 mg/kg body weight. Blood was taken in different preset times: prior and at 0.03, 0.06, 0.13, 0.25, 0.5, 1, 2, 4, 8, 12 and 24 h following drug administration. The concentrations of EFX and CFX in plasma were determined by high pressure liquid chromatography (HPLC). Plasma concentrations vs. time were analysed by a compartmental independent pharmacokinetic model that provided the most important kinetic parameters. Statistically significant differences between the two antimicrobials were found for most of the pharmacokinetic parameters: Area under the curve (AUC), area under first moment curve (AUMC), mean residence time (MRT), total body cleareance (ClB), volume of distribution beta (Vd beta) and volume of distribution at the steady state (Vd(ss)). Both antimicrobials were widely distributed in chickens throughout the body with a mean Vd(ss) of 1.98+/-0.18 L/kg for EFX, and 4.04+/-0.69 L/kg for CFX. The ClB for CFX was five times higher than that obtained for EFX. AUC, MRT and the diminished half time for EFX were two-four times higher than those obtained for CFX. These results indicate that CFX remains in the body for less time than the other quinolone. This characteristic of CFX suggests the advantage of a shorter withdrawal time for food producing animals treated with this antimicrobial.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447832     DOI: 10.1046/j.1365-2885.1999.00211.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  11 in total

1.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in male and female turkeys following intravenous and oral administration.

Authors:  D J Dimitrova; L D Lashev; St G Yanev; V T Pandova
Journal:  Vet Res Commun       Date:  2006-05       Impact factor: 2.459

2.  Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens.

Authors:  Mathias Devreese; Gunther Antonissen; Siegrid De Baere; Patrick De Backer; Siska Croubels
Journal:  BMC Vet Res       Date:  2014-12-02       Impact factor: 2.741

3.  Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration.

Authors:  Débora Cristina Sampaio de Assis; Guilherme Resende da Silva; Isabela Pereira Lanza; Ana Cláudia Dos Santos Rossi Ribeiro; Ângela Maria Quintão Lana; Leonardo José Camargos Lara; Tadeu Chaves de Figueiredo; Silvana de Vasconcelos Cançado
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

4.  In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.

Authors:  Xia Xiao; Lijie Jiang; Weixuan Lan; Yongjia Jiang; Zhiqiang Wang
Journal:  BMC Vet Res       Date:  2018-11-29       Impact factor: 2.741

5.  Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli.

Authors:  Jochen Schulz; Nicole Kemper; Joerg Hartung; Franziska Janusch; Siegrun A I Mohring; Gerd Hamscher
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

6.  Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens.

Authors:  Karina P D Bonassa; Miwa Y Miragliotta; Rosineide C Simas; Marcos N Eberlin; Arturo Anadón; Ronilson A Moreno; Felix G R Reyes
Journal:  Front Vet Sci       Date:  2021-01-07

7.  Antibiotic Resistance and Virulence Gene Patterns Associated with Avian Pathogenic Escherichia coli (APEC) from Broiler Chickens in Qatar.

Authors:  Alreem Johar; Najlaa Al-Thani; Sara H Al-Hadidi; Elyes Dlissi; Mahmoud H Mahmoud; Nahla O Eltai
Journal:  Antibiotics (Basel)       Date:  2021-05-11

8.  Enrofloxacin Dose Optimization for the Treatment of Colibacillosis in Broiler Chickens Using a Drinking Behaviour Pharmacokinetic Model.

Authors:  Robin Temmerman; Ludovic Pelligand; Wim Schelstraete; Gunther Antonissen; An Garmyn; Mathias Devreese
Journal:  Antibiotics (Basel)       Date:  2021-05-19

9.  Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.

Authors:  KaNa Sang; HaiHong Hao; LingLi Huang; Xu Wang; ZongHui Yuan
Journal:  Front Vet Sci       Date:  2016-01-07

10.  Effects of enrofloxacin treatment on the bacterial microbiota of milk from goats with persistent mastitis.

Authors:  Richard Costa Polveiro; Pedro Marcus Pereira Vidigal; Tiago Antônio de Oliveira Mendes; Ricardo Seiti Yamatogi; Magna Coroa Lima; Maria Aparecida Scatamburlo Moreira
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.